The Yin and Yang of pre-operative screening for meticillin resistant and sensitive Staphylococcus aureus (MRSA and MSSA): Does the extra effort and cost of suppression reduce surgical site infections?

Wound Medicine

Volumn 1, Issue , 2013, Pages 7-12

  Edmiston, Charles E ^a   Leaper, David ^b   Kiernan, Martin ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

MRSA; MSSA; Pre operative screening; Surgical site infection

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE GLUCONATE; DOXYCYCLINE; PSEUDOMONIC ACID; RIFAMPICIN;

ASEPSIS; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG USE; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTHCARE ASSOCIATED INFECTION; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; LABORATORY DIAGNOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; RAPID TEST; REVIEW; RISK REDUCTION; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

EID: 84883784462     PISSN: 22139095     EISSN: 22139109     Source Type: Journal    
DOI: 10.1016/j.wndm.2013.05.003     Document Type: Review

References (55)

1. Reducing Health Care Associated Infections in Hospitals in England. Report 2009, National Audit Office, London.
2. Gould I. Costs of hospital-acquired Methicillin-Resistant Staphylococcus aureus (MRSA) and its control. International Journal of Antimicrobial Agents 2006, 28:379-384.
3. Leaper D.J., van Goor H., Reilly J., Petrosillo N., Geiss H.K., Torres A.J., et al. Surgical site infection - a European perspective of incidence and economic burden. International Wound Journal 2004, 1:247-273.
4. Health Protection Agency Surveillance of surgical site infections in NHS hospitals in England 2010/2011 December 2011, Health Protection Agency, London, www.hpa.org.uk.
5. Health Protection Agency Fifth report of the mandatory surveillance of surgical site infection in orthopaedic surgery April 2004-March 2009 December 2011, Health Protection Agency, London, www.hpa.org.uk.
6. Leaper D., Tanner J., Kiernan M. Surveillance of surgical site infection: more accurate definitions and intensive recording needed. Journal of Hospital Infection 2013, 83:83-86.
7. Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infectious Diseases 2005, 5:751-762.
8. Nouwen J.L., Fierren M.W., Snijders S., et al. A persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney International 2005, 67:1084-1092.
9. Nouwen J.L., Ott A., Kluytmans-Vandenbergh M.F., et al. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule". Clinical Infectious Diseases 2004, 39:806-811.
10. Hu I., Umeda A., Kondo S., et al. Typing of Staphylococcus aureus colonizing humans nasal carriers by pulse-field gel electrophoresis. Journal of Medical Microbiology 1995, 42:127-132.
11. van Velzen E.V., Reilly J.S., Kavanagh K., Leanord A., Edwards G.F., Girvan E.K., et al. A retrospective cohort study into acquisition of MRSA and associated risk factors after implementation of universal screening in Scottish hospitals. Infection Control and Hospital Epidemiology 2011, 32:889-896.
12. Loeb M., Main C., Walker-Dilks C., Eady A. Antimicrobial drugs for treating Methicillin-resistant Staphylococcus aureus colonization. Cochrane Database of Systematic Reviews 2008, http://summaries.cochrane.org/search/site/CD003340.
13. Abad C., Fearday A., Safdar N. Adverse effects of isolation in hospitalised patients: a systematic review. Journal of Hospital Infection 2010, 76:97-102.
14. Huang S.S., Datta R., Rifas-Shiman S., Kleinman K., Placzek H., Lankiewicz J.D., et al. Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study. Critical Care 2011, 15:R210.
15. Jarvis W.R., Jarvis J.A., Chinn R.Y. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United State healthcare facilities, 2010. American Journal of Infection Control 2012, 40:194-200.
16. Jarvis W.R., Schlosser J., Chinn R.Y., et al. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US healthcare facilities, 2006. American Journal of Infection Control 2007, 35:631-637.
17. Winning ways: working together to reduce Healthcare Associated Infection in England 2003, Department of Health CMO, Department of Health, London, Contract No.: 3412.
18. Clean Your Hands Campaign National patient safety agency 2003, http://www.npsa.nhs.uk/cleanyourhands/.
19. Department of Health CMO Clean, safe care: reducing MRSA and other healthcare associated infections 2007, http://www.clean-safecare.nhs.uk/.
20. HCAI reducing healthcare associated infections. High Impact Intervention. Care bundle to prevent surgical site infection for prevention of SSI 2011, Department of Health, Available at: www.hcai.dh.gov.uk/files/2011/03/2011-03-14-HII-Prevent-Surgical-Site-in fection-FINAL.pdf.
21. Wyllie D.H., Walker A.S., Miller R., Moore C., Williamson S.R., Schlackow I., et al. Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification. British Medical Journal Open 2011, 1-9.
22. Health Protection Scotland, National Services Scotland, NHS Scotland MRSA Screening Pathfinder Programme Final Report vol. 1: an investigation of the Clinical Effectiveness of MRSA Screening 2011. Health Protection Scotland. [Report].
23. Reilly J.S., Stewart S., Christie P., Allardice G.M., Stari T., Matheson A., et al. Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study. Journal of Hospital Infection 2012, 80:31-35.
24. Weber S.G., Huang S.S., Oriola S., et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: a position statement from the joint SHEA and APIC taskforce. Infection Control and Hospital Epidemiology 2007, 28:246-249.
25. Peterson A., Marquez P., Terashita D., et al. Hospital methicillin-resistant Staphylococcus aureus active surveillance practices in Los Angeles County: implications of legislation-based infection control 2008. American Journal of Infection Control 2010, 38:653-656.
26. San Juan R., Chaves F., Gude M.J.L., et al. Staphylococcus aureus poststernotomy mediastinitis; description of two distinct acquisition pathways with different potential preventative approaches. Journal of Thoracic and Cardiovascular Surgery 2007, 134:670-676.
27. Kim D.H., Spencer M., Davidson S.M., et al. Institutional prescreening for detection and eradication of methicillin in patients undergoing elective orthopedic surgery. Journal of Bone and Joint Surgery 2010, 92:1820-1826.
28. Harbarth S., Frankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. Journal of the American Medical Association 2008, 299:1149-1157.
29. Huskins W.C., Huckabee C.M., O'Grady N.P., et al. Intervention to reduce transmission of resistant bacteria in intensive care. New England Journal of Medicine 2011, 364:1407-1418.
30. Jain R., Kralovic S.M., Evans M.E., et al. Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. New England Journal of Medicine 2011, 364:1419-1430.
31. Matheson A., Christie P., Stari T., et al. Nasal swab screening for methicillin-resistant Staphylococcus aureus - how well does it perform? A cross-sectional study. Infect Control and Hospital Epidemiology 2012, 33:803-808.
32. McKinnell J.A., Huang S.S., Eells S.J., Cui E., Miller L.G. Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control and Hospital Epidemiology 2013, 34:161-170.
33. Fry D.E., Barie P.D. The changing face of Staphylococcus aureus: a continuing surgical challenge. Surgical Infections 2011, 12:191-203.
34. Keshtqar M.R., Khalili A., Coen P.G., Carder C., Macrae B., Jeanes A., et al. Impact of rapid molecular screening for meticillin-resistant Staphylococcus aureus in surgical wards. British Journal of Surgery 2008, 95:381-386.
35. Bode L.G.M., Kluytmans A.J.W., Wertheim H.F.L., Bogaers D., Vandenbroucke-Grauls C.N.J.E., Roosendaal R., et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. New England Journal of Medicine 2010, 362:9-17.
36. Surgical site infection Prevention and treatment of surgical site infection 2008, National Institute of Health and Clinical Excellence. Clinical Guideline CG 74, Available at: www.nice.org.uk/nicemedia/live/11743/42378/42378.pdf.
37. Tacconelli E., Carmeli Y., Aizer A., et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clinical Infectious Diseases 2003, 37:1629-1638.
38. Kallen A.J., Wilson C.T., Larson R.J. Perioperative intranasal mupirocin for the prevention of surgical-site infection: systematic review of the literature and meta-analysis. Infect Control and Hospital Epidemiology 2005, 26:916-922.
39. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M., et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clinical and Infectious Diseases 2001, 35:353-358.
40. Cimochowski C.E., Harostock M.D., Brown R., et al. Intranasal mupirocin reduces sterna wound infection after open heart surgery in diabetics and nondiabetics. Annals of Thoracic Surgery 2011, 71:1572-1579.
41. Simor A.E., Phillips E., McGeez A., et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for eradication of methicillin-resistant Staphylococcus aureus colonization. Clinical and Infectious Diseases 2007, 44:178-185.
42. Patel J.B., Gorwitz R.J., Jernigam J.A. Mupirocin resistance. Clinical and Infectious Diseases 2009, 49:935-941.
43. Edgeworth J.D. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. Journal of Antimicrobial Chemotherapy 2011, 66(Suppl. ii):41-47.
44. Nouwen J., Schouten J., Schneebergen P., Snijders S., Maaskant Y., Koolen M., et al. Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. Journal of Clinical Microbiology 2006, 44:2233.
45. Batra R., Cooper B.S., Whiteley C., Patel A.K., Wyncoll D., Edgeworth J.D. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clinical Infectious Diseases 2010, 50:210-217.
46. Lucet J.-C., Regnier B. Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus?. Clinical Infectious Diseases 2010, 51:585-590.
47. Rao N., Cannella B., Crossett L.S., Yates S.J., McGough R. A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clinical and Orthopedic Related Research 2008, 466:1343-1348.
48. Coates T., Bax R., Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. Journal of Antimicrobial Chemotherapy 2009, 64:9-15.
49. Perl P.M., Cullen J.J., Wenzel R.P., Zimmmerman M.B., Pfaller M.A., Sheppard D., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. New England Journal of Medicine 2002, 346:1871-1877. the mupirocin and the risk of Staphylococcus aureus study team.
50. Peterson L.R., Liesenfeld O., Woods C.W., Allen S.D., Pombo D., et al. Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs. Journal of Clinical Microbiology 2010, 48:1661-1666.
51. Wolk D.M., Picton E., Johnson D., Davis T., Pancholi P., et al. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. Journal of Clinical Microbiology 2009, 47:758-764.
52. Buchan B.W., Ledeboer N.A. Identification of two borderline oxacillin-resistant strains of Staphylococcus aureus from routine nares swab specimens by one of three chromogenic agars evaluated for the detection of MRSA. American Journal of Clinical Pathology 2010, 134:921-927.
53. Peterson J.F., Riebe K.M., Hall G.S., Wilson D., Whittier S., Spectra M.R.S.A., et al. a new chromogenic agar medium to screen for methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology 2010, 48:215-219.
54. Carson J., Lui B., Rosmus L., Rennick H., Fuller J Interpretation of MRSA Select screening agar at 24h of incubation. Journal of Clinical Microbiology 2009, 47:566-568.
55. Desroches M., Potier J., Laurent F., Bourrel A.S., Doucet-Populaire F., Decousser J.W. Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA. Journal of Antimicrobial Chemotherapy March 2013, on behalf of the Microbs Study Group, [Epub ahead of print].